Open to: Academic | Student

This lecture is delivered once a year by Neurosurgeons and Neuroclinicians with outstanding contributions to Neurosurgery and Neuroscience. This year it will be delivered by Professor Roger Stupp, Chairman of the Oncology and Cancer Centre at the University Hospital in Zurich. Professor Stupp is one of the most well known and respected neuro-oncologists in the world today. He has validated the use of Temozolamide in the treatment of glioblastoma and his group has introduced the concept of MGMT gene silencing. The Editorial in the New England Journal of Medicine reads that his studies "represent landmarks in the diagnosis and treatment of malignant glial tumours".

Contact

Sarah Lawson
sarah.lawson@ucl.ac.uk